Hollencrest Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$79.9K Sell
721
-610
-46% -$67.6K ﹤0.01% 413
2025
Q1
$149K Sell
1,331
-3
-0.2% -$336 0.01% 306
2024
Q4
$123K Hold
1,334
﹤0.01% 345
2024
Q3
$112K Buy
1,334
+3
+0.2% +$252 ﹤0.01% 357
2024
Q2
$91.3K Hold
1,331
﹤0.01% 389
2024
Q1
$97.5K Hold
1,331
﹤0.01% 369
2023
Q4
$108K Buy
1,331
+502
+61% +$40.7K 0.01% 365
2023
Q3
$62.1K Hold
829
0.01% 439
2023
Q2
$63.9K Hold
829
0.01% 452
2023
Q1
$68.8K Hold
829
0.01% 427
2022
Q4
$71.2K Buy
+829
New +$71.2K 0.01% 389
2022
Q1
Sell
-14,609
Closed -$1.06M 381
2021
Q4
$1.06M Buy
14,609
+1,300
+10% +$94.4K 0.08% 119
2021
Q3
$929K Buy
+13,309
New +$929K 0.08% 125
2020
Q2
Sell
-12,597
Closed -$942K 308
2020
Q1
$942K Sell
12,597
-1,868
-13% -$140K 0.14% 97
2019
Q4
$940K Buy
14,465
+3,100
+27% +$201K 0.11% 117
2019
Q3
$720K Buy
11,365
+8,100
+248% +$513K 0.09% 134
2019
Q2
$220K Hold
3,265
0.03% 264
2019
Q1
$212K Hold
3,265
0.03% 259
2018
Q4
$204K Hold
3,265
0.03% 249
2018
Q3
$212K Hold
3,265
0.03% 259
2018
Q2
$231K Hold
3,265
0.03% 240
2018
Q1
$246K Buy
3,265
+42
+1% +$3.16K 0.03% 236
2017
Q4
$231K Sell
3,223
-5,800
-64% -$416K 0.03% 252
2017
Q3
$731K Buy
9,023
+1,300
+17% +$105K 0.1% 132
2017
Q2
$546K Hold
7,723
0.08% 152
2017
Q1
$525K Buy
7,723
+4,210
+120% +$286K 0.08% 172
2016
Q4
$252K Sell
3,513
-730
-17% -$52.4K 0.04% 246
2016
Q3
$336K Sell
4,243
-51
-1% -$4.04K 0.05% 229
2016
Q2
$358K Sell
4,294
-4,394
-51% -$366K 0.06% 238
2016
Q1
$798K Buy
8,688
+94
+1% +$8.63K 0.14% 125
2015
Q4
$870K Sell
8,594
-1,430
-14% -$145K 0.15% 118
2015
Q3
$984K Buy
10,024
+345
+4% +$33.9K 0.17% 102
2015
Q2
$1.13M Sell
9,679
-2,003
-17% -$234K 0.16% 106
2015
Q1
$1.15M Buy
11,682
+4,773
+69% +$469K 0.15% 108
2014
Q4
$652K Buy
6,909
+1,532
+28% +$145K 0.09% 164
2014
Q3
$572K Buy
5,377
+238
+5% +$25.3K 0.08% 171
2014
Q2
$426K Buy
5,139
+1,332
+35% +$110K 0.06% 218
2014
Q1
$270K Buy
3,807
+181
+5% +$12.8K 0.04% 289
2013
Q4
$272K Buy
+3,626
New +$272K 0.04% 245